RT Journal Article
T1 SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).
A1 Sepulveda-Sanchez, J M
A1 Muñoz-Langa, J
A1 Arraez, M A
A1 Fuster, J
A1 Hernandez Lain, A
A1 Reynes, G
A1 Rodriguez-Gonzalez, V
A1 Vicente, E
A1 Vidal-Denis, M
A1 Gallego, O
K1 Astrocytoma
K1 Guideline
K1 Low-grade glioma
K1 Neurooncology
K1 Oligodendroglioma
AB Diffuse infiltrating low-grade gliomas include oligodendrogliomas and astrocytomas, and account for about 5% of all primary brain tumors. Treatment strategies for these low-grade gliomas in adults have recently changed. The 2016 World Health Organization (WHO) classification has updated the definition of these tumors to include their molecular characterization, including the presence of isocitrate dehydrogenase (IDH) mutation and 1p/19p codeletion. In this new classification, the histologic subtype of grade II-mixed oligoastrocytoma has also been eliminated. The precise optimal management of patients with low-grade glioma after resection remains to be determined. The risk-benefit ratio of adjuvant treatment must be weighed for each individual.
PB Springer
YR 2017
FD 2017-11-09
LK http://hdl.handle.net/10668/11787
UL http://hdl.handle.net/10668/11787
LA en
NO Sepúlveda-Sánchez JM, Muñoz Langa J, Arráez MÁ, Fuster J, Hernández Laín A, Reynés G, et al. SEOM clinical guideline of diagnosis and management of low-grade glioma (2017). Clin Transl Oncol. 2018 Jan;20(1):3-15
DS RISalud
RD Apr 18, 2025